Pharmacodynamics and Pharmacokinetics of Different Glucose Bead Formulations in Obese Healthy Subjects

NCT05737927 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Obese

Interventions

DRUG: Glucose 8 g coated beads (47% w/w)
DRUG: Glucose 12 g coated beads (47% w/w)
DRUG: Glucose 16 g coated beads (47% w/w)
DRUG: Glucose 12 g uncoated beads
DRUG: Glucose 12 g coated beads (60% w/w)
DRUG: Glucose 12 g coated beads (47% w/w)

Sponsor

Aphaia Pharma US LLC

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]